Contact Us   Having technical issues or questions regarding this product?
Please Contact Us.
BEI Resources currently limits the total number of "Made to Order" items which can be ordered by a registrant to 10 "Made to Order" items per 6 month period. Please check the Availability Status on the items you are ordering and limit orders appropriately.
NR-546  Vaccinia virus, (WR) B5R Protein with N-terminal Histidine Tag, Recombinant from Baculovirus
(Proteins)
Price: All BEI Resources products are provided
at no cost to registered researchers.
Description: (WR) B5R Protein with N-terminal Histidine Tag, Recombinant from Baculovirus
Organism: Vaccinia virus
Biosafety Level: 1
Availability Status: In Stock
Store at: -60°C or colder
Contributor: GH Cohen, RJ Eisenberg
Comments:
Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.

NR-546 is a recombinant form of the B5R membrane glycoprotein [B5R(275t); residues 20 to 275 comprising the ectodomain, N-terminal histidine-tagged] of the Western Reserve (WR) strain of vaccinia virus. The full length B5R protein is 317 residues. NR-546 was produced in Sf9 insect cells using a baculovirus expression system and was purified using ammonium sulfate precipitation and nickel affinity chromatography. NR-546 was demonstrated to be functionally active based on its reactivity with human polyclonal anti-vaccinia virus immune globulin (VIG) and monoclonal antibodies to B5R (BEI Resources NR-422 to NR-424, NR-426 to NR-431, NR-551 to NR-556, and NR-559 to NR-562).

Each vial contains approximately 0.5 mg of NR-546 in 50 mM borate buffer (pH 8) containing 100 mM NaCl.
Citations: Acknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH: Vaccinia Virus (WR) B5R Protein with N-terminal Histidine Tag, Recombinant from baculovirus, NR-546."
Publications Citing
this Reagent:
Garber, D. A., et al. "Deletion of Specific Immune Modulatory Genes from Modified Vaccinia Ankara-Based HIV Vaccines Engenders Improved Immunogenicity in Rhesus Macaques." J. Virol. 86 (2012): 12605-12615. PubMed: 22973033.
PERMITS
For a list of permits that may be required for shipping this product and to set the permit information preferences; please select a country from the drop down below.

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.

Return to Top


Notices and Disclaimers

BEI Resources products are intended for laboratory research purposes only. They are not intended for use in humans.

While BEI Resources uses reasonable efforts to include accurate and up-to-date information on this site, BEI Resources makes no warranties or representations as to its accuracy. Citations from scientific literature and patents are provided for informational purposes only. BEI Resources does not warrant that such information has been confirmed to be accurate.


Back to My Search